These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38568913)

  • 1. Earnings management and readability of CSR report: Evidence from China.
    Ren B; Yao S
    PLoS One; 2024; 19(4):e0301187. PubMed ID: 38568913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
    Zhang Y; Yang F
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do financial performance and firm's value affect the quality of corporate social responsibility disclosure: Moderating role of chief executive officer's power in China.
    Na C; Tian G; Rauf F; Naveed K
    Front Psychol; 2022; 13():925323. PubMed ID: 36059787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corporate social responsibility, financing constraints, and corporate carbon intensity: new evidence from listed Chinese companies.
    Chen P
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):40107-40115. PubMed ID: 36609966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does more voluntary environmental information disclosure cut down the cost of equity: heavy pollution industries in China.
    Wendai L; Jing F; Bin L
    Environ Sci Pollut Res Int; 2022 Sep; 29(42):62913-62940. PubMed ID: 35840829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental Regulation, Corporate Social Responsibility (CSR) Disclosure and Enterprise Green Innovation: Evidence from Listed Companies in China.
    Xu X; Jing R; Lu F
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of corporate environmental responsibility on financial performance-based on Chinese listed companies.
    Liu Y; Xi B; Wang G
    Environ Sci Pollut Res Int; 2021 Feb; 28(7):7840-7853. PubMed ID: 33040290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of voluntary disclosure on financial performance: Empirical study on manufacturing industry in Indonesia.
    Meiryani ; Huang SM; Soepriyanto G; Jessica ; Fahlevi M; Grabowska S; Aljuaid M
    PLoS One; 2023; 18(6):e0285720. PubMed ID: 37267373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation Efficiency of Corporate Social Responsibility in the Construction Industry: A China Study.
    Wang X; Lai W; Song X; Lu C
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nexus of the CSR disclosures and corporate financial performance: evidence from Asian countries climate policy uncertainty.
    Waris M; Din BH
    Environ Sci Pollut Res Int; 2024 Jan; 31(2):1995-2008. PubMed ID: 38049691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantity, Quality, and Performance of Corporate Social Responsibility Information Disclosure by Listed Enterprises in China: A Regional Perspective.
    Zhang H; Zhang Z; Tan A; Steklova E
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32230705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
    Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
    PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the "Veil" of information disclosure: Sustainability reporting "greenwashing" and "shared value".
    Xu W; Li M; Xu S
    PLoS One; 2023; 18(1):e0279904. PubMed ID: 36652406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparation of differences in the performance of corporate social responsibility between Chinese and American pharmaceutical enterprises-based on corporate social responsibility report.
    Xu H; Zhang M; Chu S
    Front Pharmacol; 2023; 14():1116466. PubMed ID: 37284320
    [No Abstract]   [Full Text] [Related]  

  • 16. Earnings management in socially responsible firms around seasoned equity offerings: Evidence from France, Germany, Italy and Spain.
    González-Sánchez M; Segovia San Juan AI; Ibáñez Jiménez EM
    Heliyon; 2023 Apr; 9(4):e15171. PubMed ID: 37077692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common institutional investors and the quality of management earnings forecasts-Empirical and machine learning evidences.
    Yang S; Li X; Jiang Z; Xiao M
    PLoS One; 2023; 18(10):e0290126. PubMed ID: 37844110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smog, media attention, and corporate social responsibility-empirical evidence from Chinese polluting listed companies.
    Xiong G; Luo Y
    Environ Sci Pollut Res Int; 2021 Sep; 28(34):46116-46129. PubMed ID: 33410010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Mandatory Disclosure Policies Promote Corporate Environmental Responsibility?-Quasi-Natural Experimental Research on China.
    Liu Y; Failler P; Chen L
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34205230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.